St Germain D J CO Inc Regeneron Pharmaceuticals, Inc. Transaction History
St Germain D J CO Inc
- $2.04 Billion
- Q1 2025
A detailed history of St Germain D J CO Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, St Germain D J CO Inc holds 22 shares of REGN stock, worth $12,389. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22Holding current value
$12,389% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding REGN
# of Institutions
1,499Shares Held
87MCall Options Held
1.53MPut Options Held
1.44M-
Vanguard Group Inc Valley Forge, PA9.29MShares$5.23 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.76 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$3.98 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.72 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$2.67 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $60.4B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...